Mutant cartilage oligomeric matrix protein (COMP) compromises bone integrity, joint function and the balance between adipogenesis and osteogenesis

Posey, 2014, Pseudoachondroplasia/COMP - translating from the bench to the bedside, Matrix Biol., 37, 167, 10.1016/j.matbio.2014.05.006 Di Cesare, 1997, Expression of cartilage oligomeric matrix protein by human synovium, FEBS Lett., 412, 249, 10.1016/S0014-5793(97)00789-8 Schulz, 2016, COMP-assisted collagen secretion—a novel intracellular function required for fibrosis, J. Cell Sci., 129, 706 Acharya, 2014, Cartilage oligomeric matrix protein and its binding partners in the cartilage extracellular matrix: interaction, regulation and role in chondrogenesis, Matrix Biol., 37, 102, 10.1016/j.matbio.2014.06.001 Adams, 2001, Thrombospondins: multifunctional regulators of cell interactions, Annu. Rev. Cell Dev. Biol., 17, 25, 10.1146/annurev.cellbio.17.1.25 Sodersten, 2005, Ultrastructural immunolocalization of cartilage oligomeric matrix protein (COMP) in relation to collagen fibrils in the equine tendon, Matrix Biol., 24, 376, 10.1016/j.matbio.2005.06.003 Di Cesare, 2002, Matrix-matrix interaction of cartilage oligomeric matrix protein and fibronectin, Matrix Biol., 21, 461, 10.1016/S0945-053X(02)00015-X Murphy-Ullrich, 2014, Revisiting the matricellular concept, Matrix Biol., 37, 1, 10.1016/j.matbio.2014.07.005 Halasz, 2007, COMP acts as a catalyst in collagen fibrillogenesis, J. Biol. Chem., 282, 31166, 10.1074/jbc.M705735200 Svensson, 2002, Cartilage oligomeric matrix protein-deficient mice have normal skeletal development, Mol. Cell. Biol., 22, 4366, 10.1128/MCB.22.12.4366-4371.2002 Briggs, 1995, Pseudoachondroplasia and multiple epiphyseal dysplasia due to mutations in the cartilage oligomeric matrix protein gene, Nat. Genet., 10, 330, 10.1038/ng0795-330 Hecht, 1995, Mutations in exon 17B of cartilage oligomeric matrix protein (COMP) cause pseudoachondroplasia, Nat. Genet., 10, 325, 10.1038/ng0795-325 Unger, 2001, Pseudoachondroplasia and multiple epiphyseal dysplasia: new etiologic developments, Am. J. Med. Genet., 106, 244, 10.1002/ajmg.10234 McKeand, 1996, Natural history study of pseudoachondroplasia, Am. J. Med. Genet., 63, 406, 10.1002/(SICI)1096-8628(19960517)63:2<406::AID-AJMG16>3.0.CO;2-O Posey, 2008, The role of cartilage oligomeric matrix protein (COMP) in skeletal disease, Curr. Drug Targets, 9, 869, 10.2174/138945008785909293 Hecht, 1998, Characterization of cartilage oligomeric matrix protein (COMP) in human normal and pseudoachondroplasia musculoskeletal tissues, Matrix Biol., 17, 269, 10.1016/S0945-053X(98)90080-4 Hecht, 2005, COMP mutations, chondrocyte function and cartilage matrix, Matrix Biol., 23, 525, 10.1016/j.matbio.2004.09.006 Posey, 2009, An inducible cartilage oligomeric matrix protein mouse model recapitulates human pseudoachondroplasia phenotype, Am. J. Pathol., 175, 1555, 10.2353/ajpath.2009.090184 Duke, 2003, Apoptosis staining in cultured pseudoachondroplasia chondrocytes, Apoptosis, 8, 191, 10.1023/A:1022926811397 Hecht, 2001, Grp94 and BiP chaperone proteins are associated with retained COMP in pseudoachondroplasia chondrocytes, Matrix Biol., 20, 251, 10.1016/S0945-053X(01)00136-6 Vranka, 2001, Selective intracellular retention of extracellular matrix proteins and chaperones associated with pseudoachondroplasia, Matrix Biol., 20, 439, 10.1016/S0945-053X(01)00148-2 Hecht, 2004, Chondrocyte cell death and intracellular distribution of COMP and type IX collagen in the pseudoachondroplasia growth plate, J. Orthop. Res., 22, 759, 10.1016/j.orthres.2003.11.010 Merritt, 2007, Unique matrix structure in the rough endoplasmic reticulum cisternae of pseudoachondroplasia chondrocytes, Am. J. Pathol., 170, 293, 10.2353/ajpath.2007.060530 Hecht, 1998, Retention of cartilage oligomeric matrix protein (COMP) and cell death in redifferentiated pseudoachondroplasia chondrocytes, Matrix Biol., 17, 625, 10.1016/S0945-053X(98)90113-5 Merritt, 2006, Expression of mutant cartilage oligomeric matrix protein in human chondrocytes induces the pseudoachondroplasia phenotype, J. Orthop. Res., 24, 700, 10.1002/jor.20100 Posey, 2012, Chop (Ddit3) is essential for D469del-COMP retention and cell death in chondrocytes in an inducible transgenic mouse model of pseudoachondroplasia, Am. J. Pathol., 180, 727, 10.1016/j.ajpath.2011.10.035 Coustry, 2012, D469del-COMP retention in chondrocytes stimulates caspase-independent necroptosis, Am. J. Pathol., 180, 738, 10.1016/j.ajpath.2011.10.033 Guan, 2015, miR-223 regulates adipogenic and osteogenic differentiation of mesenchymal stem cells through a C/EBPs/miR-223/FGFR2 regulatory feedback loop, Stem Cells, 33, 1589, 10.1002/stem.1947 Posey, 2015, Antioxidant and anti-inflammatory agents mitigate pathology in a mouse model of pseudoachondroplasia, Hum. Mol. Genet., 24, 3918, 10.1093/hmg/ddv122 Scheller, 2014, What's the matter with MAT? Marrow adipose tissue, metabolism, and skeletal health, Ann. N. Y. Acad. Sci., 1311, 14, 10.1111/nyas.12327 Cox, 2013, Alterations to the subchondral bone architecture during osteoarthritis: bone adaptation vs endochondral bone formation, Osteoarthr. Cartil., 21, 331, 10.1016/j.joca.2012.10.013 Briggs, 1993, Pseudoachondroplasia Caplan, 1991, Mesenchymal stem cells, J. Orthop. Res., 9, 641, 10.1002/jor.1100090504 Horwitz, 2005, Clarification of the nomenclature for MSC: the International Society for Cellular Therapy position statement, Cytotherapy, 7, 393, 10.1080/14653240500319234 Meyer, 2016, Epigenetic plasticity drives adipogenic and osteogenic differentiation of marrow-derived mesenchymal stem cells, J. Biol. Chem., 291, 17829, 10.1074/jbc.M116.736538 Berry, 2015, Adipose tissue residing progenitors (adipocyte lineage progenitors and adipose derived stem cells (ADSC)), Curr. Mol. Biol. Rep., 1, 101, 10.1007/s40610-015-0018-y Lian, 2012, MicroRNA control of bone formation and homeostasis, Nat. Rev. Endocrinol., 8, 212, 10.1038/nrendo.2011.234 Fang, 2015, MicroRNAs regulate bone development and regeneration, Int. J. Mol. Sci., 16, 8227, 10.3390/ijms16048227 Hamam, 2015, microRNAs as regulators of adipogenic differentiation of mesenchymal stem cells, Stem Cells Dev., 24, 417, 10.1089/scd.2014.0331 Chen, 2016, Fate decision of mesenchymal stem cells: adipocytes or osteoblasts?, Cell Death Differ., 23, 1128, 10.1038/cdd.2015.168 Lin, 2016, Selective enrichment of microRNAs in extracellular matrix vesicles produced by growth plate chondrocytes, Bone, 88, 47, 10.1016/j.bone.2016.03.018 Rilla, 2017, Extracellular vesicles are integral and functional components of the extracellular matrix, Matrix Biol. Rendina-Ruedy, 2017, Bone-fat interaction, Endocrinol. Metab. Clin. N. Am., 46, 41, 10.1016/j.ecl.2016.09.004 Matsui, 2016, Effects of miR-223 on expression of IL-1beta and IL-6 in human gingival fibroblasts, J. Oral Sci., 58, 101, 10.2334/josnusd.58.101 Liu, 2015, miR-223 is upregulated in monocytes from patients with tuberculosis and regulates function of monocyte-derived macrophages, Mol. Immunol., 67, 475, 10.1016/j.molimm.2015.08.006 Kim, 2014, Peroxisomal dysfunction is associated with up-regulation of apoptotic cell death via miR-223 induction in knee osteoarthritis patients with type 2 diabetes mellitus, Bone, 64, 124, 10.1016/j.bone.2014.04.001 Coustry, 2012, D469del COMP retention in chondrocytes stimulates caspase-independent necroptosis, Am. J. Pathol., 180, 738, 10.1016/j.ajpath.2011.10.033 Okuhara, 2012, Changes in microRNA expression in peripheral mononuclear cells according to the progression of osteoarthritis, Mod. Rheumatol., 22, 446, 10.3109/s10165-011-0536-2 Bouxsein, 2003, Bone quality: where do we go from here?, Osteoporos. Int., 14 Currey, 2001, Bone strength: what are we trying to measure?, Calcif. Tissue Int., 68, 205, 10.1007/s002230020040 Gamble, 2015, Pseudoachondroplasia and painful sequelae, Am. J. Med. Genet. A, 167, 2618, 10.1002/ajmg.a.37253 Hernandez, 2017, Understanding bone strength is not enough, J. Bone Miner. Res., 32, 1157, 10.1002/jbmr.3078 Inzana, 2013, Bone fragility beyond strength and mineral density: Raman spectroscopy predicts femoral fracture toughness in a murine model of rheumatoid arthritis, J. Biomech., 46, 723, 10.1016/j.jbiomech.2012.11.039 Porter, 2005, Effect of carbonate substitution on the ultrastructural characteristics of hydroxyapatite implants, J. Mater. Sci. Mater. Med., 16, 899, 10.1007/s10856-005-4424-1 Follet, 2004, The degree of mineralization is a determinant of bone strength: a study on human calcanei, Bone, 34, 783, 10.1016/j.bone.2003.12.012 Brandt, 2006, Yet more evidence that osteoarthritis is not a cartilage disease, Ann. Rheum. Dis., 65, 1261, 10.1136/ard.2006.058347 Loeser, 2012, Osteoarthritis: a disease of the joint as an organ, Arthritis Rheum., 64, 1697, 10.1002/art.34453 Cross, 1996, Clinical terminology for describing knee instability, Sports Med. Arthrosc. Rev., 4, 313 van der Esch, 2006, Joint laxity and the relationship between muscle strength and functional ability in patients with osteoarthritis of the knee, Arthritis Rheum., 55, 953, 10.1002/art.22344 Asahara, 2017, Tendons and ligaments: connecting developmental biology to musculoskeletal disease pathogenesis, J. Bone Miner. Res., 32, 1773, 10.1002/jbmr.3199 Catuogno, 2015, Selective delivery of therapeutic single strand antimiRs by aptamer-based conjugates, J. Control. Release, 210, 147, 10.1016/j.jconrel.2015.05.276 Posey, 2017, Antisense reduction of mutant COMP reduces growth plate chondrocyte pathology, Mol. Ther., 25, 705, 10.1016/j.ymthe.2016.12.024